IL10 and colitis: We demonstrated that Gls1 inhibition by BPTES ameliorated colitis in IL‐10−/− mice, as shown by histopathology and by reductions in inflammation scores and the DAI, which was associated with significantly decreased Th1 and Th17 responses but increased Treg responses.